Aurora Cannabis Inc. (TSE:ACB - Get Free Report)'s share price traded down 20.2% during mid-day trading on Thursday . The stock traded as low as C$6.31 and last traded at C$6.40. 1,868,867 shares traded hands during mid-day trading, an increase of 257% from the average session volume of 523,132 shares. The stock had previously closed at C$8.02.
Aurora Cannabis Trading Down 20.2%
The company has a debt-to-equity ratio of 18.72, a quick ratio of 2.48 and a current ratio of 3.42. The business's 50 day moving average price is C$6.97 and its 200-day moving average price is C$6.70. The company has a market cap of C$350.13 million, a price-to-earnings ratio of -7.90 and a beta of 2.71.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
